It was further stated by Enloe and Jay that inhibition of CD155 by RNAi caused a decrease in tumour invasion in part through reduced activity of matrix metalloproteinase-2 (MMP-2), a known factor in GBM invasion [22]. The gene discussed is MMP2; the disease is neoplasm.